We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
2626
Intel
INTC
$503B
$2K ﹤0.01%
49
-135,335
-100% -$4.9M
JACK icon
2627
Jack in the Box
JACK
$331M
$2K ﹤0.01%
23
-54
-70% -$5.59K
JLS icon
2628
Nuveen Mortgage and Income Fund
JLS
$94.6M
$2K ﹤0.01%
+69
New +$1.68K
LARK icon
2629
Landmark Bancorp
LARK
$196M
$2K ﹤0.01%
149
-396
-73% -$7.62K
LHX icon
2630
L3Harris
LHX
$53.9B
$2K ﹤0.01%
20
-4,101
-100% -$439K
LMAT icon
2631
LeMaitre Vascular
LMAT
$1.85B
$2K ﹤0.01%
+100
New +$2.35K
LOCO icon
2632
El Pollo Loco
LOCO
$499M
$2K ﹤0.01%
200
-642
-76% -$7.87K
LRCX icon
2633
Lam Research
LRCX
$383B
$2K ﹤0.01%
130
-16,780
-99% -$197K
LSTA icon
2634
Lisata Therapeutics
LSTA
$9.74M
$2K ﹤0.01%
+20
New +$1.39K
MATW icon
2635
Matthews International
MATW
$863M
$2K ﹤0.01%
+31
New +$2.15K
MBSD icon
2636
FlexShares Disciplined Duration MBS Index Fund
MBSD
$88.7M
$2K ﹤0.01%
+100
New +$2.41K
MCI
2637
Barings Corporate Investors
MCI
$343M
$2K ﹤0.01%
152
+2
+1% +$30
MIND icon
2638
MIND Technology
MIND
$46.7M
$2K ﹤0.01%
+33
New +$1.53K
MNOV icon
2639
MediciNova
MNOV
$66.9M
$2K ﹤0.01%
300
-2,901
-91% -$17.5K
MOMO
2640
Hello Group
MOMO
$855M
$2K ﹤0.01%
+46
New +$1.23K
MRTN icon
2641
Marten Transport
MRTN
$1.21B
$2K ﹤0.01%
250
-1,403
-85% -$13.3K
MTEX icon
2642
Mannatech
MTEX
$9.84M
$2K ﹤0.01%
119
-230
-66% -$4.24K
MTG icon
2643
MGIC Investment
MTG
$6.21B
$2K ﹤0.01%
161
-11,138
-99% -$117K
NDAQ icon
2644
Nasdaq
NDAQ
$52.9B
$2K ﹤0.01%
81
-9,726
-99% -$226K
NKTR icon
2645
Nektar Therapeutics
NKTR
$2.48B
$2K ﹤0.01%
7
-60
-90% -$13.5K
NRIM icon
2646
Northrim BanCorp
NRIM
$591M
$2K ﹤0.01%
264
-1,984
-88% -$14.7K
NTIP icon
2647
Network-1 Technologies
NTIP
$37M
$2K ﹤0.01%
+400
New +$1.58K
NVAX icon
2648
Novavax
NVAX
$1.27B
$2K ﹤0.01%
85
+60
+240% +$1.65K
ODP
2649
DELISTED
ODP
ODP
$2K ﹤0.01%
43
-8,981
-100% -$406K
OUT icon
2650
Outfront Media
OUT
$5.48B
$2K ﹤0.01%
81
+51
+170% +$1.33K

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.